Glaxosmithkline Intellectual Property (No.5) Limited
Private Limited Company · Liverpool
Members Voluntary Liquidation (MVL, solvent)United KingdomIncorporated 2019Private Limited Company
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
1 without an end date · 0 ceasedGlaxo Group LimitedCorporate
Shares: over 75%, up to 100%Voting rights: over 75%, up to 100%Right to appoint or remove directors
Notified 2019-04-23 · No cessation recorded
Source record 131075505People behind the business
Current appointments and the wider business interests of each person.
Appointments
2 current · 11 historicalAppointed 2019-04-23 · 7 yrs
Show 11 historical appointments
CB
Cristina Barcelo IglesiasResigned director
Resigned 2024-09-23 · Vp Oncology, R&D Finance
DG
Demet Gurunlu RussResigned director
Resigned 2024-06-25 · Director
JR
Jemma ReynoldsResigned director
Resigned 2024-04-04 · Vp R&D Finance, Respiratory & Immunology
GR
Gregory ReinaudResigned director
Resigned 2024-01-30 · Director
JA
Jill Dawn AndersonResigned director
Resigned 2023-03-01 · 1 yr · Director
ZS
Ziba ShamsiResigned director
Resigned 2022-10-28 · Director
JW
James WheatcroftResigned director
Resigned 2019-07-01 · 4 yrs · Vp Controller R & D Director
KP
Kate PriestmanResigned director
Resigned 2019-04-23 · 3 yrs · None
JA
Jerome AndriesResigned director
Resigned 2019-04-23 · 3 yrs · Director
CorpThe Wellcome Foundation LimitedResigned director
Resigned 2019-04-23 · 5 yrs
AW
Adam WalkerResigned director
Resigned 2019-04-23 · 5 yrs · Director
Board profile
- People with appointments
- 2
- Directors assessed
- 1
- Median age
- 55
- Under 35
- 0
- 65 and over
- 0
- Disqualified match
- None active